EARNEST Partners’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-132
Closed -$12.3K 515
2023
Q3
$12.3K Hold
132
﹤0.01% 585
2023
Q2
$17K Hold
132
﹤0.01% 520
2023
Q1
$15.3K Hold
132
﹤0.01% 531
2022
Q4
$14.9K Hold
132
﹤0.01% 534
2022
Q3
$11K Hold
132
﹤0.01% 570
2022
Q2
$10K Hold
132
﹤0.01% 602
2022
Q1
$17K Hold
132
﹤0.01% 524
2021
Q4
$18K Hold
132
﹤0.01% 517
2021
Q3
$18K Hold
132
﹤0.01% 507
2021
Q2
$14K Hold
132
﹤0.01% 563
2021
Q1
$12K Hold
132
﹤0.01% 580
2020
Q4
$12K Hold
132
﹤0.01% 567
2020
Q3
$14K Hold
132
﹤0.01% 475
2020
Q2
$13K Hold
132
﹤0.01% 490
2020
Q1
$9K Hold
132
﹤0.01% 531
2019
Q4
$7K Hold
132
﹤0.01% 659
2019
Q3
$5K Hold
132
﹤0.01% 743
2019
Q2
$5K Hold
132
﹤0.01% 756
2019
Q1
$4K Hold
132
﹤0.01% 810
2018
Q4
$4K Hold
132
﹤0.01% 765
2018
Q3
$5K Hold
132
﹤0.01% 755
2018
Q2
$3K Hold
132
﹤0.01% 918
2018
Q1
$2K Hold
132
﹤0.01% 982
2017
Q4
$2K Buy
+132
New +$1.72K ﹤0.01% 979
2017
Q1
Sell
-132
Closed -$2K 427
2016
Q4
$2K Buy
+132
New +$2.34K ﹤0.01% 909

Other funds holding DXCM

EARNEST Partners's DXCM Position: Q4 2023 in Review

EARNEST Partners sold out of DexCom (DXCM) in Q4 2023, closing a stake of 132 shares — an estimated $12.3K sold.

EARNEST Partners first reported a position in DXCM in Q4 2016 and held it in 25 quarters. The position peaked at $18K in Q4 2021. 975 funds tracked by Wall St. Rank hold DXCM as of Q4 2023.

  • EARNEST Partners reported no remaining DexCom position as of Q4 2023 after selling out during the quarter.
  • EARNEST Partners sold 132 DexCom shares in Q4 2023, an estimated $12.3K.
  • EARNEST Partners first reported a position in DexCom in Q4 2016 and held it in 25 quarters.
  • EARNEST Partners's DexCom position peaked at $18K in Q4 2021.
  • 975 funds tracked by Wall St. Rank held DexCom as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.